Cargando…

Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice

Achieving durable protective immunity following vaccination is dependent on many factors, including vaccine composition and antigen dose, and it has been investigated for various types of vaccines. Aim of the present study was to investigate the overall immune response elicited by two different boos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Catalioto, Rose-Marie, Valenti, Claudio, Bellucci, Francesca, Cialdai, Cecilia, Altamura, Maria, Digilio, Laura, Pellacani, Andrea Ugo Enrico, Meini, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239470/ https://www.ncbi.nlm.nih.gov/pubmed/34195422 http://dx.doi.org/10.1016/j.heliyon.2021.e07314

Ejemplares similares

Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)
por: Waye, Arianna, et al.
Publicado: (2015)

Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales
por: Choi, Yoon Hong, et al.
Publicado: (2012)

From “Glivec(®)” to “Prevnar 13(®)”: How strong is the Indian drug patenting system?
por: Raj, Gerard Marshall
Publicado: (2018)

1432. County-Wide Pediatric IPD Experience Following Prevnar 13 Implementation
por: Nieves, Delma, et al.
Publicado: (2018)

Rapid kinetics of serum IgA after vaccination with Prevnar(®)13 followed by Pneumovax(®)23
por: Crowther, Rebecca R., et al.
Publicado: (2017)

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older
por: Buchwald, Ulrike K., et al.
Publicado: (2021)

Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003–2008)
por: Waye, Arianna, et al.
Publicado: (2015)

A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
por: Reglinski, Mark, et al.
Publicado: (2018)

Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly
por: Dalla Gasperina, Daniela, et al.
Publicado: (2023)

Development of humoral immunity
por: Kanellopoulos, Jean M., et al.
Publicado: (2019)

Humoral Innate Immunity and Acute-Phase Proteins
por: Mantovani, Alberto, et al.
Publicado: (2023)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
por: van der Lee, Saskia, et al.
Publicado: (2018)

The Effects of Isolated Fractions of Mesobuthus eupeus Scorpion Venom on Humoral Immune Response
por: Khosravi, Mohammad, et al.
Publicado: (2017)

Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling
por: Ai, Jingwen, et al.
Publicado: (2022)

Humoral Immune Response to AAV
por: Calcedo, Roberto, et al.
Publicado: (2013)

Specific humoral immunity in Osteichthyes
por: Stosik, Michał P., et al.
Publicado: (2018)

Humoral Immunity to Hantavirus Infection
por: Engdahl, Taylor B., et al.
Publicado: (2020)

Humoral Immunity vs. Salmonella
por: Takaya, Akiko, et al.
Publicado: (2020)

Impact of Prevnar vaccination on nasopharyngeal carriage of Streptococcus pneumoniae in healthy children in New Caledonia
por: Scotet, Julie, et al.
Publicado: (2011)

Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice
por: Gao, Feng-Xia, et al.
Publicado: (2022)

Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers
por: Szczepanek, Steven M., et al.
Publicado: (2016)

Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccination
por: Yu-ping, Zhao, et al.
Publicado: (2023)

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human
por: Zhang, Yuwei, et al.
Publicado: (2022)

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
por: Kim, Eun, et al.
Publicado: (2023)

Humoral and cell-mediated immunity to cytomegaloviruses.
por: Rytel, M. W.
Publicado: (1976)

MATURATION OF THE HUMORAL IMMUNE RESPONSE IN MICE
por: Spear, Patricia G., et al.
Publicado: (1974)

Humoral innate immune response and disease
por: Shishido, Stephanie N., et al.
Publicado: (2012)

Vaccination to gain humoral immune memory
por: Sarkander, Jana, et al.
Publicado: (2016)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

Speculations on the evolution of humoral adaptive immunity
por: Horton, Miles B, et al.
Publicado: (2020)

Humoral Immunity Against Aspergillus fumigatus
por: Dellière, Sarah, et al.
Publicado: (2023)

Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models
por: Wu, Fengbo, et al.
Publicado: (2017)

Sculpting humoral immunity through dengue vaccination to enhance protective immunity
por: Crill, Wayne D., et al.
Publicado: (2012)

How to Naturally Support the Immune System in Inflammation—Essential Oils as Immune Boosters
por: Grazul, Magdalena, et al.
Publicado: (2023)

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
por: Glück, Vivian, et al.
Publicado: (2022)

Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study
por: Yang, Lu M., et al.
Publicado: (2022)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
por: Hastert, Florian D., et al.
Publicado: (2022)

Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
por: Karakizlis, Hristos, et al.
Publicado: (2022)

Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2022)

Association between Adverse Reactions and Humoral Immune Response No Longer Detectable after BNT162b2 Booster Vaccination
por: Bauernfeind, Stilla, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_je6t0oga9kh76086n1h1qg90ib